Pinned
Exciting to see these results out! Lots to build on - congratulations @ superb MSK pancreas team (no biases!) and complex insightful analyses led by @CentralParkWMD @MSKCancerCenter and as #ASCO23 winds down…. back to the real work of implementing all the learnings to practice!
Pembro + olaparib maintenece #POLAR trial (B&C) in non-BRCA potential #HRD stage IV #PancreaticCancer n=30. Well-tolerated. 30% had no progression for > 6mo WITHOUT chemo. Deep science & POLAR A #BRCA awaited. #gratitude & 💜to MSK team & patients #ASCO23 t.ly/D9gl
